» Articles » PMID: 18004186

Daily Stress and Gastrointestinal Symptoms in Women with Irritable Bowel Syndrome

Overview
Journal Nurs Res
Specialty Nursing
Date 2007 Nov 16
PMID 18004186
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Stress has been implicated as contributing to the initiation and exacerbation of bowel and discomfort symptoms in patients with irritable bowel syndrome (IBS).

Objective: To examine the relationships of daily self-reported stress to gastrointestinal (GI) and psychological distress symptoms both across women and within woman in a comparison group of women without IBS and among subgroups of women with IBS.

Methods: Women with IBS (n = 181; age = 18-49 years) who were divided into subgroups based on bowel pattern (constipation, n = 52; diarrhea, n = 67; alternating, n = 62) were compared to a group of women without IBS (n = 48). Self-report stress measures; abdominal (abdominal pain, bloating, and intestinal gas), bowel pattern (constipation, diarrhea), and intestinal gas; and psychological (anxiety and depression) distress symptoms were obtained daily over 1 month. Across-women and within-woman analyses were used.

Results: There were significant across-women correlations among mean daily stress, psychological distress, and GI symptoms in the total IBS group and the IBS bowel pattern subgroups. The across-women relationships between daily stress and GI symptoms were diminished when anxiety and depression were controlled in the analyses. Within-woman analyses showed little evidence of relationship between day-to-day variations in stress and day-to-day variations in GI symptoms; however, stress was strongly related to anxiety and depression.

Discussion: Gastrointestinal symptom distress is associated with self-reported stress in women with IBS. Psychological distress moderates the effects of stress on GI symptoms. The IBS treatment protocols that incorporate strategies that decrease stress and psychological distress are likely to reduce GI symptoms.

Citing Articles

The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea Domination: A Randomized Controlled Trial.

Jafari S, Atmani A, Gohari S, Seifi E Middle East J Dig Dis. 2024; 16(3):178-184.

PMID: 39386337 PMC: 11459287. DOI: 10.34172/mejdd.2024.386.


Masculinity, Rather Than Biological Sex, Is Associated With Psychological Comorbidities in Patients With Irritable Bowel Syndrome.

Kim Y, Lee J, Kim J, Kang S, Park J, Kim H J Neurogastroenterol Motil. 2024; 30(3):361-372.

PMID: 38321628 PMC: 11238104. DOI: 10.5056/jnm23012.


Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?.

Fang X, Fan W, Drossman D, Han S, Ke M World J Gastroenterol. 2022; 28(33):4861-4874.

PMID: 36156921 PMC: 9476853. DOI: 10.3748/wjg.v28.i33.4861.


Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance.

Orock A, Yuan T, Greenwood-Van Meerveld B Front Pain Res (Lausanne). 2022; 1:609292.

PMID: 35295688 PMC: 8915633. DOI: 10.3389/fpain.2020.609292.


Prevalence and risk factor for chronic diarrhea in participants of a Japanese medical checkup.

Matsumoto Y, Nadatani Y, Otani K, Higashimori A, Ominami M, Fukunaga S JGH Open. 2022; 6(1):69-75.

PMID: 35071791 PMC: 8762620. DOI: 10.1002/jgh3.12704.